For the full functioning of the joint, cartilage tissue is present in the body. Normally, a synovial fluid is constantly produced in its cavity , which consists of chondroitin and glucosamine. These components by their nature belong to the category of polysaccharides. They are continuously synthesized by cartilage cells. Differing in mucous structure, glucosamine and chondroitin provide unobstructed gliding of articular surfaces during movement. Over the years, the amount of substances produced in the body decreases sharply. There is a need to obtain from the outside this desired polysaccharide. One of the medicines that includes chondroitin is Mucosat-Belmed. Instructions for use characterize it as an excellent anti-inflammatory agent.
Composition and form of release
The active component of the drug is chondroitin. It is obtained from cattle trachea. The substance has the following characteristics:
- inhibits the resorption of tissues;
- accelerates the process of cartilage regeneration;
- prevents compression of connective tissue;
- reduces the leaching of calcium from the body;
- inhibits the deformation of cartilage;
- improves calcium and phosphorus metabolism.
Pharmaceutical companies produce the drug "Mucosat-Belmed" in several dosage forms: capsules, tablets, solution for intramuscular injection. The most popular option among patients is injections. The solution for parenteral administration is a clear liquid with the smell of alcohol. One ampoule contains 100 mg of chondroitin sulfate. Five such ampoules are placed in a cell package.
Capsules of the drug are cylindrical in shape with rounded edges. Inside the pill is a white substance in the form of a powder. Capsules and tablets contain 250 mg of the active substance.
Pharmacological properties
"Mucosat-Belmed" is a chondroprotector and belongs to the group of slow-acting drugs. The use of the medication helps to increase the release of synovial fluid, reduce inflammation and pain, as well as reduce the need for the use of non-steroidal anti-inflammatory drugs.
The active component of the drug is rapidly absorbed. Its maximum concentration in the blood is observed after 30 minutes. Over the next 48 hours, the drug content in the body gradually decreases. Chondroitin accumulates primarily in cartilage. The therapeutic effect of the drug develops slowly, but persists for 5-6 months. Mucosat-Belmed, like other chondroprotectors, is effective only in the initial stages of the development of the disease. In the later stages, he is not able to stop the process of cartilage deformation.
Indications for use
According to the instructions, this tool is prescribed for the treatment of dystrophic and degenerative conditions of the spine, as well as joints. In addition, the use of the drug is justified for the following pathologies:
- fractures
- periodontopathy;
- primary arthrosis;
- osteoporosis.
"Mucosat-Belmed" is recommended for use for the prevention and / or treatment of joint damage due to excessive physical exertion.
Instructions for use
According to the annotation to the drug, it is recommended to repeat Mucosat injections every other day in a single ampoule. The course of treatment is 3 days. Then the amount of the drug must be doubled and continue to give injections every other day. The total course of therapy includes 25-35 injections. If necessary, it can be repeated after 6 months.
Capsules or tablets, the instruction recommends taking three pills orally twice a day. This treatment regimen should be followed for 3 weeks. Then the dosage must be reduced to two pills twice a day. The general course of therapy should not exceed 1.5 months.
For children under 5 years of age, the drug "Belmed-Mukosat" is prescribed only in tablets of 500 mg per day. The duration of the pill is determined by the doctor.
Contraindications
The medication is distinguished by its effectiveness and is well tolerated by patients. It is important to consider that it can not be used in all cases. The instruction for the drug does not recommend its use in the following diseases:
- vein thrombophlebitis;
- poor blood coagulability;
- individual sensitivity to the components of the drug.
It is also recommended to abandon the medication during pregnancy and lactation. If treatment cannot be neglected according to indications, it is necessary to stop breastfeeding while taking the tablets.
How much does Mucosat Belmed cost?
The price of a medicine depends not only on the form of release, but also on the region of sale. For example, you will have to pay at least 500 rubles for packing capsules. The cost of the solution for injection is slightly higher and is approximately 700 rubles.
Analogues of the drug
Pharmaceutical companies offer consumers a wide range of chondroprotectors. All of them differ in their composition and price. What analogues can be replaced by Mukosat-Belmed? Patient reviews indicate that the following medications are most effective: Structum, Khodroksid and Arthron Chondrex. They also have active ingredient chondroitin. Drugs differ only in cost and contraindications.
What do patients say?
The anti-inflammatory drug described in the article is distinguished by positive reviews. Patients who have used the drug speak of its effectiveness and the absence of side effects. Many patients report improvement during the first weeks of treatment. Joint pain gradually decreases, their mobility increases markedly. Positive dynamics is also noted in the treatment of intervertebral hernias with the Mukosat-Belmed drug.
Reviews with a negative color are due to the appearance of painful seals and hematomas at the injection site. The medication has an oily base, so in some cases it does not absorb well. The tablet form of the drug is used extremely rarely in Russia, so there are practically no reviews about its use.